CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Common stock	Preferred stock	Nonvested restricted stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Retained earnings	Total
Beginning balance, value at Dec. 31, 2022	$ 80		$ (3,306)	$ 119,027	$ (13,410)	$ 192,121	$ 294,512
Beginning balance shares outstanding at Dec. 31, 2022	8,011,045
Net income						5,161	5,161
Proceeds from exercise of stock options	$ 1			184			185
Proceeds from exercise of stock options (in Shares)	11,000
Issuance of restricted stock, net of forfeitures			(1,436)	1,436
Issuance of restricted stock (in Shares)	36,393
Compensation expense related to restricted stock, net of tax			691				691
Compensation expense related to stock options, net of tax				265			265
Other comprehensive income (loss)					700		700
Ending balance, value at Jun. 30, 2023	$ 81		(4,051)	120,912	(12,710)	197,282	301,514
Ending balance shares outstanding at Jun. 30, 2023	8,058,438
Beginning balance, value at Mar. 31, 2023	$ 80		(4,462)	120,683	(11,775)	194,824	299,350
Beginning balance shares outstanding at Mar. 31, 2023	8,047,975
Net income						2,458	2,458
Proceeds from exercise of stock options	$ 1			168			169
Proceeds from exercise of stock options (in Shares)	10,000
Issuance of restricted stock, net of forfeitures			85	(85)
Issuance of restricted stock (in Shares)	463
Compensation expense related to restricted stock, net of tax			326				326
Compensation expense related to stock options, net of tax				146			146
Other comprehensive income (loss)					(935)		(935)
Ending balance, value at Jun. 30, 2023	$ 81		(4,051)	120,912	(12,710)	197,282	301,514
Ending balance shares outstanding at Jun. 30, 2023	8,058,438
Beginning balance, value at Dec. 31, 2023	$ 81		(3,596)	121,777	(11,342)	205,547	312,467
Beginning balance shares outstanding at Dec. 31, 2023	8,088,186
Net income						5,521	5,521
Proceeds from exercise of stock options				167			167
Proceeds from exercise of stock options (in Shares)	11,000
Issuance of restricted stock, net of forfeitures	$ 1		(2,035)	2,034
Issuance of restricted stock (in Shares)	55,911
Compensation expense related to restricted stock, net of tax			921				921
Compensation expense related to stock options, net of tax				196			196
Other comprehensive income (loss)					(524)		(524)
Ending balance, value at Jun. 30, 2024	$ 82		(4,710)	124,174	(11,866)	211,068	318,748
Ending balance shares outstanding at Jun. 30, 2024	8,155,097
Beginning balance, value at Mar. 31, 2024	$ 82		(5,257)	124,159	(11,797)	208,069	315,256
Beginning balance shares outstanding at Mar. 31, 2024	8,156,109
Net income						2,999	2,999
Proceeds from exercise of stock options
Issuance of restricted stock, net of forfeitures			78	(78)
Issuance of restricted stock (in Shares)	(1,012)
Compensation expense related to restricted stock, net of tax			469				469
Compensation expense related to stock options, net of tax				93			93
Other comprehensive income (loss)					(69)		(69)
Ending balance, value at Jun. 30, 2024	$ 82		$ (4,710)	$ 124,174	$ (11,866)	$ 211,068	$ 318,748
Ending balance shares outstanding at Jun. 30, 2024	8,155,097